|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 81.06 EUR | +0.15% |
|
-1.97% | -13.54% |
| 05:10am | Sanofi Says Efdoralprin Alfa Gets Orphan Drug Designation in EU | MT |
| 02:45am | Orphan drug designation in the DAAT for Sanofi |  |
Chart calendar Sanofi
Upcoming events on Sanofi
| 2026-01-29 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-29 | Q4 2025 Earnings Call | Add to your calendar Google Apple ICS format |
| 2026-04-22 | Q1 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 2026-04-23 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-07-29 | Q2 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 2026-07-30 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-10-29 | Q3 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 2026-10-30 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 2027-01-28 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-04-28 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-07-28 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2027-10-21 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Sanofi
| 2025-12-16 | Business Update Call |
| 2025-12-03 | Citi Global Healthcare Conference |
| 2025-12-02 | Evercore Healthcare Conference |
| 2025-11-19 | Jefferies Global Healthcare Conference |
| 2025-11-13 | Deutsche Bank R&D Series |
| 2025-11-12 | Buy-side Healthcare CEO Summit |
| 2025-11-10 | Guggenheim Healthcare Innovation Conference |
| 2025-10-24 | Q3 2025 Earnings Call |
| 2025-10-24 | Q3 2025 Earnings Release |
| 2025-09-24 | Baader Investment Conference |
| 2025-09-23 | Bank of America Global Healthcare Conference |
| 2025-09-09 | Morgan Stanley Global Healthcare Conference |
| 2025-09-08 | Kepler Cheuvreux Autumn Conference |
| 2025-09-03 | Wells Fargo Healthcare Conference |
| 2025-09-03 | J.P. Morgan European Healthcare CEO Call Series |
| 2025-07-31 | Q2 2025 Earnings Call |
| 2025-07-31 | Q2 2025 Earnings Release |
| 2025-07-09 | Leerink Partners Therapeutics Forum |
| 2025-06-25 | International Society on Thrombosis and Haemostasis Congress - Ghanima |
| 2025-06-24 | International Society on Thrombosis and Haemostasis Congress - Khoo |
Past dividends on Sanofi
| 2025-05-11 | Annual 3.92 EUR |
| 2024-05-12 | Annual 3.76 EUR |
| 2023-05-29 | Annual 3.56 EUR |
| 2022-05-05 | Annual 3.33 EUR |
| 2021-05-04 | Annual 3.2 EUR |
| 2020-05-03 | Annual 3.15 EUR |
| 2019-05-08 | Annual 3.07 EUR |
| 2018-05-10 | Annual 3.03 EUR |
| 2017-05-15 | Annual 2.96 EUR |
| 2016-05-09 | Annual 2.93 EUR |
| 2015-05-10 | Annual 2.85 EUR |
| 2014-05-11 | Annual 2.8 EUR |
| 2013-05-08 | Annual 2.77 EUR |
| 2012-05-09 | Annual 2.65 EUR |
| 2011-05-15 | Annual 2.5 EUR |
| 2010-05-19 | Annual 2.4 EUR |
| 2009-04-22 | Annual 2.2 EUR |
| 2008-05-15 | Annual 2.07 EUR |
| 2007-06-06 | Annual 1.75 EUR |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 42 997 43 479 -1.11% | 43 070 43 966 -2.04% | 41 081 43 574 -5.72% | 43 461 | 46 514 | 49 472 |
|
EBITDA Million EUR | Released Forecast Spread | 14 627 14 574 0.36% | 14 259 13 722 3.91% | 12 889 13 227 -2.56% | 13 387 | 14 422 | 15 404 |
|
EBIT Million EUR | Released Forecast Spread | 13 040 12 965 0.58% | 12 670 12 363 2.48% | 11 343 12 078 -6.08% | 12 041 | 13 048 | 13 977 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 8 268 8 304 -0.44% | 7 038 9 458 -25.59% | 6 997 7 118 -1.7% | 9 380 | 10 525 | 11 656 |
|
Net income Million EUR | Released Forecast Spread | 6 720 7 446 -9.75% | 5 400 7 748 -30.31% | 5 744 7 863 -26.95% | 8 429 | 8 470 | 9 322 |
|
EPS EUR | Released Forecast Spread | 5,37 5,86 -8.39% | 4,31 6,19 -30.32% | 4,59 5,88 -21.96% | 6,94 | 6,99 | 7,72 |
| Announcement Date | 03/02/23 | 01/02/24 | 30/01/25 | - |
Quarterly results
| Fiscal Period | June | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 S1 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 10 919 10 989 -0.64% | 10 464 10 208 2.51% | 10 745 10 377 3.55% | 13 438 12 670 6.06% | 10 564 10 440 1.19% | 9 895 9 748 1.51% | 9 994 9 987 0.07% | 19 889 19 709 0.91% | 12 434 12 237 1.61% | 11 114 | 10 120 | 10 765 | 13 610 | 12 475 |
|
EBITDA Million EUR | Released Forecast Spread | 3 009 2 863 5.11% | 3 192 2 991 6.73% | 3 210 2 770 15.89% | 5 057 4 205 20.26% | 2 428 2 462 -1.38% | 3 251 2 839 14.53% | 2 795 2 603 7.36% | 4 842 4 376 10.64% | 2 491 | 2 670 | 2 683 | 4 726 | 3 531 | |
|
EBIT Million EUR | Released Forecast Spread | 2 583 2 714 -4.81% | 2 843 2 680 6.07% | 2 813 2 678 5.05% | 4 607 4 038 14.1% | 2 078 2 152 -3.44% | 2 902 2 663 8.97% | 2 461 2 587 -4.88% | 5 363 | 4 445 4 138 7.42% | 2 203 | 2 642 | 2 840 | 4 805 | 2 755 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -249 2 408 -110.34% | 1 310 1 829 -28.38% | 1 416 2 011 -29.59% | 3 581 3 523 1.65% | 1 070 1 334 -19.79% | 2 158 2 304 -6.34% | 3 512 3 674 -4.41% | 1 798 | ||||||
|
Net income Million EUR | Released Forecast Spread | -555 1 592 -134.85% | 1 133 1 601 -29.24% | 1 113 1 522 -26.86% | 2 815 2 691 4.63% | 683 4 230 -83.85% | 1 872 1 726 8.48% | 3 939 4 251 -7.35% | 2 802 2 853 -1.79% | 1 198 | 1 677 | 1 590 | 3 211 | 1 843 | |
|
EPS EUR | Released Forecast Spread | -0,44 1,27 -134.75% | 0,91 1,28 -28.71% | 0,89 1,22 -27.16% | 2,25 2,14 5.08% | 0,54 3,36 -83.93% | 1,52 1,39 9.23% | 3,24 3,74 -13.48% | 2,30 2,33 -1.47% | 0,94 | 1,38 | 1,31 | 2,65 | 1,53 | |
| Announcement Date | 01/02/24 | 25/04/24 | 25/07/24 | 25/10/24 | 30/01/25 | 24/04/25 | 31/07/25 | 31/07/25 | 24/10/25 | - | - | - | - | - |
| 2025-12-21 |  | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-05 | | Q3 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-11 | | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-15 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-20 | | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-21 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 2026-01-22 | | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past sector events for Sanofi
| 2025-12-10 | | November 2025 Sales and Revenue Release |
| 2025-12-10 | | November 2025 Sales and Revenue Release |
| 2025-12-09 | | Q2 2026 Earnings Release |
| 2025-12-09 | | November 2025 Sales and Revenue Release |
| 2025-12-09 | | November 2025 Sales and Revenue Release |
| 2025-12-05 | | November 2025 Sales and Revenue Release |
| 2025-11-30 | | Q3 2025 Earnings Release |
| 2025-11-27 | | Q2 2026 Earnings Release |
| 2025-11-19 | | Q3 2025 Earnings Release |
| 2025-11-14 | | Q2 2026 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SAN Stock
- Calendar Sanofi
Select your edition
All financial news and data tailored to specific country editions
